This inventor holds 1 USPTO granted patent. Top assignees: Case Western Reserve University, The Cleveland Clinic Foundation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,371 
1 out of 1,077 
Years Active: 2012
Title: Kutralanathan Reganathan and His Patent on Inhibiting Angiogenesis
Introduction
Kutralanathan Reganathan is an inventor associated with Cleveland, Ohio. His work includes a patent concerning approaches to inhibit angiogenesis, the formation of new blood vessels, in conditions involving the eye.
Latest Patents
Reganathan is associated with 1 patent: “Methods of Reducing Angiogenesis of Age-Related Macular Degeneration (AMD) or Choroidal Neovascularization by an Anti-Carboxyethylpyrrole (CEP) Antibody.” The invention describes administering an agent that inhibits the angiogenic activity of CEP protein adducts. It focuses on reducing ocular angiogenesis and choroidal neovascularization, processes linked in the patent description to oxidative modification of polyunsaturated fatty acids.
Career Highlights
Reganathan’s listed organizational affiliations include Case Western Reserve University and The Cleveland Clinic Foundation. These institutions are associated with research and healthcare in Cleveland.
Collaborations
His listed coworkers include Bela Anand-Apte and John W. Crabb. Their names appear alongside Reganathan in connection with his professional and patent-related work.
Conclusion
Kutralanathan Reganathan’s patent addresses a potential strategy for inhibiting abnormal blood-vessel growth associated with age-related macular degeneration and choroidal neovascularization.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile